Solid‐Phase Synthesis and Biological Evaluation of Peptides ADP‐Ribosylated at Histidine
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202313317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Hugo Minnee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, RA-2300, Leiden (The, Netherlands. Hauptthemen laut MEDLINE: Histidine, Solid-Phase Synthesis Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
The transfer of an adenosine diphosphate (ADP) ribose moiety to a nucleophilic side chain by consumption of nicotinamide adenine dinucleotide is referred to as ADP‐ribosylation, which allows for the spatiotemporal regulation of vital processes such as apoptosis and DNA repair. Recent mass‐spectrometry based analyses of the “ADP‐ribosylome” have identified histidine as ADP‐ribose acceptor site. In order to study this modification, a fully synthetic strategy towards α‐configured N(τ)‐ and N(π)‐ADP‐ribosylated histidine‐containing peptides has been developed. Ribofuranosylated histidine building blocks were obtained via Mukaiyama‐type glycosylation and the building blocks were integrated into an ADP‐ribosylome derived peptide sequence using fluorenylmethyloxycarbonyl (Fmoc)‐based solid‐phase peptide synthesis. On‐resin installation of the ADP moiety was achieved using phosphoramidite chemistry, and global deprotection provided the desired ADP‐ribosylated oligopeptides. The stability under various chemical conditions and resistance against (ADP‐ribosyl) hydrolase‐mediated degradation has been investigated to reveal that the constructs are stable under various chemical conditions and non‐degradable by any of the known ADP‐ribosylhydrolases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bio-Organic Synthesis, Leiden Institute of Chemistry, Leiden University, RA-2300, Leiden (The, Netherlands.
- Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.
- Current address: Medical Research Council Centre for Medical Mycology at the University of Exeter, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, EX4 4QD, UK.
ORCID-Profile: Dmitri V Filippov
Förderung
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- Wellcome Trust
- Medical Research Council Centre for Medical Mycology
- Cancer Research UK Therapeutic Discovery Laboratories
- Ovarian Cancer Research Alliance
Zitieren
APA
Minnee, H., Rack, J. G. M., van der Marel, G. A., Overkleeft, H. S., Codée, J. D. C., Ahel, I., & Filippov, D. V. (2024). Solid‐Phase Synthesis and Biological Evaluation of Peptides ADP‐Ribosylated at Histidine. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202313317
Vancouver
Minnee H, Rack JGM, van der Marel GA, Overkleeft HS, Codée JDC, Ahel I, et al. Solid‐Phase Synthesis and Biological Evaluation of Peptides ADP‐Ribosylated at Histidine. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202313317
BibTeX
@article{Minnee2024,
author = {Minnee, Hugo and Rack, Johannes G M and van der Marel, Gijsbert A and Overkleeft, Herman S and Codée, Jeroen D C and Ahel, Ivan and Filippov, Dmitri V},
title = {Solid‐Phase Synthesis and Biological Evaluation of Peptides ADP‐Ribosylated at Histidine},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202313317}
}
EUVIMED